Zdrowie i gospodarka · 28/05/2004

FDA Publishes Guidance on User Fees and Refunds for 510(k) Submissions

The Food and Drug Administration (FDA) has released a new guidance document outlining the user fees and refunds associated with the 510(k) premarket notification program, which is now in effect and open to public comment.